Recent trends in T7 phage application in diagnosis and treatment of various diseases
- PMID: 35978521
- DOI: 10.1016/j.intimp.2022.109071
Recent trends in T7 phage application in diagnosis and treatment of various diseases
Abstract
The T7 phage is a virulent phage hosted by Escherichia coli, which poses no threat to animals and plants. Due to the advantages of small genome, well elucidated functional genomics, fast life cycle, and high stability, T7 phage has been widely used in many fields, including biology and medicine. In this review, we focus on the research of T7 phages in biological sciences and medicine, including the application of T7 phages and T7 phage products, T7 phage display systems, and recombinant T7 phages in the treatment and diagnosis of infectious diseases (bacteria, viruses, parasites) and tumor diseases. In addition, we also introduce the therapeutic application of T7 phage in various diseases such as allergic reaction, Alzheimer's disease, inflammatory reaction, and other diseases, and finally discuss the future direction of T7 phage application in the biomedical field.
Keywords: Bacteria; Parasites; T7 phage; Tumors; Viruses.
Copyright © 2022 Elsevier B.V. All rights reserved.
Similar articles
-
Construction of Leaderless-Bacteriocin-Producing Bacteriophage Targeting E. coli and Neighboring Gram-Positive Pathogens.Microbiol Spectr. 2021 Sep 3;9(1):e0014121. doi: 10.1128/Spectrum.00141-21. Epub 2021 Jul 14. Microbiol Spectr. 2021. PMID: 34259542 Free PMC article.
-
Programming virulent bacteriophages by developing a multiplex genome engineering method.mBio. 2025 Jun 11;16(6):e0358224. doi: 10.1128/mbio.03582-24. Epub 2025 May 23. mBio. 2025. PMID: 40407328 Free PMC article.
-
Isolation, genome sequencing and functional analysis of two T7-like coliphages of avian pathogenic Escherichia coli.Gene. 2016 May 10;582(1):47-58. doi: 10.1016/j.gene.2016.01.049. Epub 2016 Jan 29. Gene. 2016. PMID: 26828615
-
Advances in the T7 phage display system (Review).Mol Med Rep. 2018 Jan;17(1):714-720. doi: 10.3892/mmr.2017.7994. Epub 2017 Nov 7. Mol Med Rep. 2018. PMID: 29115536 Review.
-
T7 Phage as an Emerging Nanobiomaterial with Genetically Tunable Target Specificity.Adv Sci (Weinh). 2022 Feb;9(4):e2103645. doi: 10.1002/advs.202103645. Epub 2021 Dec 16. Adv Sci (Weinh). 2022. PMID: 34914854 Free PMC article. Review.
Cited by
-
Phage-based peptides for pancreatic cancer diagnosis and treatment: alternative approach.Front Microbiol. 2023 Aug 2;14:1231503. doi: 10.3389/fmicb.2023.1231503. eCollection 2023. Front Microbiol. 2023. PMID: 37601380 Free PMC article. Review.
-
Ecology and Evolutionary Biology of Hindering Phage Therapy: The Phage Tolerance vs. Phage Resistance of Bacterial Biofilms.Antibiotics (Basel). 2023 Jan 25;12(2):245. doi: 10.3390/antibiotics12020245. Antibiotics (Basel). 2023. PMID: 36830158 Free PMC article. Review.
-
Advancements in ovarian cancer immunodiagnostics and therapeutics via phage display technology.Front Immunol. 2024 May 28;15:1402862. doi: 10.3389/fimmu.2024.1402862. eCollection 2024. Front Immunol. 2024. PMID: 38863706 Free PMC article. Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical